• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Irinotecan/5-fluorouracil/leucovorin in advanced colorectal cancer: Oncologic Drugs Advisory committee summary.

出版信息

Clin Colorectal Cancer. 2002 May;2(1):8-10.

PMID:12453328
Abstract
摘要

相似文献

1
Irinotecan/5-fluorouracil/leucovorin in advanced colorectal cancer: Oncologic Drugs Advisory committee summary.
Clin Colorectal Cancer. 2002 May;2(1):8-10.
2
Postmarketing re-evaluation of irinotecan plus 5-fluorouracil/leucovorin for first-line treatment of metastatic colorectal cancer.
Clin Colorectal Cancer. 2002 May;2(1):11-2. doi: 10.1016/S1533-0028(11)70495-9.
3
[Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].伊立替康在晚期结直肠癌治疗中的应用及近期研究进展
Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):718-9.
4
Irinotecan as first-line treatment of colorectal cancer: new indication. A modest advantage.伊立替康作为结直肠癌的一线治疗：新适应症。适度优势。
Prescrire Int. 2001 Apr;10(52):41-3.
5
[Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].伊立替康联合氟尿嘧啶和亚叶酸钙治疗晚期结直肠癌
Nihon Rinsho. 2003 Sep;61 Suppl 7:360-3.
6
A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.对伊立替康、奥沙利铂和雷替曲塞治疗晚期结直肠癌的临床有效性和成本效益证据进行的快速系统评价。
Health Technol Assess. 2001;5(25):1-128.
7
Lessons learned from the Saltz and Mayo Clinic regimens.从萨尔茨和梅奥诊所方案中吸取的经验教训。
Clin Colorectal Cancer. 2002 May;2(1):13. doi: 10.1016/S1533-0028(11)70496-0.
8
Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
Expert Opin Pharmacother. 2008 May;9(7):1223-8. doi: 10.1517/14656566.9.7.1223.
9
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.贝伐珠单抗、伊立替康、亚叶酸和氟尿嘧啶静脉推注（BIFF 方案）每两周 1 次治疗转移性结直肠癌的疗效和耐受性：意大利南部肿瘤协作组的经验。
Clin Colorectal Cancer. 2011 Mar 1;10(1):42-7. doi: 10.3816/CCC.2011.n.006.
10
FDA approves irinotecan as first-line therapy for colorectal cancer.
Oncology (Williston Park). 2000 May;14(5):652, 654.